RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Level Biotechnology Stock

Level Biotechnology P/E 2024

Level Biotechnology P/E

16.2

Ticker

3118.TWO

ISIN

TW0003118006

As of Aug 25, 2024, Level Biotechnology's P/E ratio was 16.2, a -2.41% change from the 16.6 P/E ratio recorded in the previous year.

The Level Biotechnology P/E history

Level Biotechnology Aktienanalyse

What does Level Biotechnology do?

Level Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Level Biotechnology's P/E Ratio

The Price to Earnings (P/E) Ratio of Level Biotechnology is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Level Biotechnology's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Level Biotechnology is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Level Biotechnology’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Level Biotechnology stock

What is the price-to-earnings ratio of Level Biotechnology?

The price-earnings ratio of Level Biotechnology is currently 16.2.

How has the price-earnings ratio of Level Biotechnology changed compared to last year?

The price-to-earnings ratio of Level Biotechnology has increased by -2.41% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Level Biotechnology high compared to other companies?

Yes, the price-to-earnings ratio of Level Biotechnology is high compared to other companies.

How does an increase in the price-earnings ratio of Level Biotechnology affect the company?

An increase in the price-earnings ratio of Level Biotechnology would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Level Biotechnology affect the company?

A decrease in the price-earnings ratio of Level Biotechnology would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Level Biotechnology?

Some factors that influence the price-earnings ratio of Level Biotechnology are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Level Biotechnology pay?

Over the past 12 months, Level Biotechnology paid a dividend of 1.7 TWD . This corresponds to a dividend yield of about 5.24 %. For the coming 12 months, Level Biotechnology is expected to pay a dividend of 1.7 TWD.

What is the dividend yield of Level Biotechnology?

The current dividend yield of Level Biotechnology is 5.24 %.

When does Level Biotechnology pay dividends?

Level Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Level Biotechnology?

Level Biotechnology paid dividends every year for the past 2 years.

What is the dividend of Level Biotechnology?

For the upcoming 12 months, dividends amounting to 1.7 TWD are expected. This corresponds to a dividend yield of 5.24 %.

In which sector is Level Biotechnology located?

Level Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Level Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Level Biotechnology from 7/12/2024 amounting to 1.7 TWD, you needed to have the stock in your portfolio before the ex-date on 6/18/2024.

When did Level Biotechnology pay the last dividend?

The last dividend was paid out on 7/12/2024.

What was the dividend of Level Biotechnology in the year 2023?

In the year 2023, Level Biotechnology distributed 1.9 TWD as dividends.

In which currency does Level Biotechnology pay out the dividend?

The dividends of Level Biotechnology are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Level Biotechnology

Our stock analysis for Level Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Level Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.